Insulet Corporation [PODD] stock is trading at $178.01, up 4.69%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PODD shares have gain 8.51% over the last week, with a monthly amount drifted -0.88%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 3, April 2024, Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024. In a post published today on Yahoo Finance, Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2024 on May 9, 2024 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on December 21, 2023, when Robert W. Baird upgraded its rating to a Outperform and also boosted its price target to $238 from $180. Previously, Morgan Stanley upgraded its rating to Overweight on December 04, 2023, and elevated its price target to $234. On October 02, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $240 on the stock. Citigroup upgraded its rating to a Buy and decreased its price target to $265 on August 21, 2023. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $219 on August 21, 2023. In a note dated January 26, 2023, Wolfe Research initiated an Peer Perform rating.
Insulet Corporation [PODD] stock has fluctuated between $125.82 and $335.91 over the past year. Currently, Wall Street analysts expect the stock to reach $300.92 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $178.01 at the most recent close of the market. An investor can expect a potential return of 69.05% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 1.70B for the trailing twelve months, which represents a growth of 37.90%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.34 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 172.37 points at the first support level, and at 166.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 181.57, and for the 2nd resistance point, it is at 185.13.
Insulet Corporation [PODD] reported earnings per share of $1.4 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.66/share, meaning a difference of $0.74 and a surprise factor of 112.10%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.71 per share as compared to estimates of $0.4 per share, a difference of $0.31 representing a surprise of 77.50%.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 3.47. Also, the Quick Ratio is 2.58, while the Cash Ratio stands at 1.44. Considering the valuation of this stock, the price to sales ratio is 7.34, the price to book ratio is 16.98 and price to earnings (TTM) ratio is 61.12.
Transactions by insiders
Recent insider trading involved Petrovic Shacey, Director, that happened on Feb 28 ’24 when 11609.0 shares were sold. Director, BORIO LUCIANA completed a deal on Dec 15 ’23 to sell 72.0 shares. Meanwhile, Director Petrovic Shacey sold 20000.0 shares on Nov 13 ’23.
